Rotavirus vaccine attenuated pentavalent - Hilleman Laboratories
Alternative Names: HSRV; Pentavalent heat-stable rotavirus vaccineLatest Information Update: 23 Feb 2022
At a glance
- Originator MSD Wellcome Trust Hilleman Laboratories
- Class Attenuated vaccines; Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Rotavirus infections
Most Recent Events
- 23 Feb 2022 Phase-II clinical trials in Rotavirus infections (In adolescents, In children, In infants, Prevention, In adults) in Bangladesh (PO) before February 2022 (MSD Wellcome Trust Hilleman Laboratories' pipeline, February 2022)
- 01 Apr 2017 MSD Wellcome Trust Hilleman Laboratories and Parexel completes a phase I/II trial in Rotavirus infections (Prevention, In infants, In adults, In children, In adolescents) in Bangladesh (PO) (NCT02728869)